These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 4281484
1. Involuntary movements other than Parkinsonism: biochemical aspects. Curzon G. Proc R Soc Med; 1973 Sep; 66(9):873-6. PubMed ID: 4281484 [No Abstract] [Full Text] [Related]
2. [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system]. Campanella G, Orefice G, Carrieri P, Mandarini A, Buscaino GA. Acta Neurol (Napoli); 1976 Sep; 31(5):571-9. PubMed ID: 138341 [No Abstract] [Full Text] [Related]
9. CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders. Davidson DL, Yates CM, Mawdsley C, Pullar IA, Wilson H. J Neurol Neurosurg Psychiatry; 1977 Dec; 40(12):1136-41. PubMed ID: 591981 [Abstract] [Full Text] [Related]
10. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders. Cramer H, Warter JM, Renaud B. Adv Neurol; 1984 Dec; 40():431-5. PubMed ID: 6198888 [No Abstract] [Full Text] [Related]
13. Monoamine transmitters and their metabolites in the basal ganglia of Huntington's disease and control postmortem brain. Walsh FX, Bird ED, Stevens TJ. Adv Neurol; 1982 Dec; 35():165-9. PubMed ID: 6183949 [No Abstract] [Full Text] [Related]
14. Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases. Barkhatova VP, Kandel' EI, Demina EG. Neurosci Behav Physiol; 1985 Dec; 15(2):132-9. PubMed ID: 3160969 [No Abstract] [Full Text] [Related]
15. Parkinson's disease and benign essential tremor: somatostatin-like immunoreactivity in the cerebrospinal fluid. Christensen SE, Dupont E, Mondrup K, Olivarius BF, Orskov H. Adv Neurol; 1984 Dec; 40():325-31. PubMed ID: 6229980 [No Abstract] [Full Text] [Related]
16. Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid. Cohen DJ, Shaywitz BA, Johnson WT, Bowers M. Arch Gen Psychiatry; 1974 Dec; 31(6):845-53. PubMed ID: 4441252 [No Abstract] [Full Text] [Related]
17. [Parkinson's disease: neuro-anatomical, biochemical and pharmicotherapeutic aspects]. Korf J, van Praagen HM, Lakke JP. Ned Tijdschr Geneeskd; 1975 Sep 06; 119(36):1373-8. PubMed ID: 241026 [No Abstract] [Full Text] [Related]
18. Dopaminergic nervous transmission in Parkinson's disease. Rinne UK, Sonninen V, Riekkinen P, Laaksonen H. Med Biol; 1974 Jun 06; 52(3):208-17. PubMed ID: 4371255 [No Abstract] [Full Text] [Related]
19. Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders. Tabaddor K, Wolfson LI, Sharpless NS. Neurology; 1978 Dec 06; 28(12):1249-53. PubMed ID: 569783 [Abstract] [Full Text] [Related]
20. Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia. Lindvall B, Olsson JE. Adv Neurol; 1990 Dec 06; 53():117-22. PubMed ID: 1700581 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]